Aclaris Therapeutics (ACRS) Earnings
|
Expand Research on ACRS
| Next EPS Date | 8/12/26 | EPS Growth Rate | -23.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.6% | Revenue Growth Rate | -22.0% |
| Average % Move 1-Wk after EPS | +1.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.16 | N/A | N/A | $1.38M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.15 | -$0.16 | +$0.01 | $2M | $1.2M | N/A |  | | Details | |
| 2/26/26 |
Q425 | -$0.16 | -$0.15 | -$0.01 | $1.3M | $1.94M | N/A | | | Details | |
| 11/6/25 |
Q325 | -$0.12 | -$0.13 | +$0.01 | $3.3M | $1.36M | N/A | | | Details | |
| 8/7/25 |
Q225 | -$0.13 | -$0.14 | +$0.01 | $1.77M | $1.28M | N/A | | | Details | |
| 5/8/25 |
Q125 | -$0.12 | -$0.14 | +$0.02 | $1.46M | $4.09M | N/A | | | Details | |
| 2/27/25 | Q424 | $0.00 | -$0.29 | +$0.29 | $9.21M | $2.08M | N/A | | | Details | |
| 2/26/25 |
Q424 | N/A | -$0.29 | N/A | N/A | $2.08M | N/A | N/A | N/A |
